Japanese encephalitis
Information
- Disease name
- Japanese encephalitis
- Disease ID
- DOID:10844
- Description
- "A viral infectious disease that results_in infection located_in brain, has_material_basis_in Japanese encephalitis virus, which is transmitted_by Culex tritaeniorhynchus mosquito bite. The infection has_symptom headache, has_symptom high fever, has_symptom neck stiffness, has_symptom stupor, has_symptom disorientation, has_symptom coma, has_symptom tremors, has_symptom convulsions, and has_symptom spastic paralysis." [url:http\://www.cdc.gov/ncidod/dvbid/arbor/arbdet.htm, url:http\://www.cdc.gov/ncidod/dvbid/jencephalitis/qa.htm]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04817917 | Active, not recruiting | Phase 4 | Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province | March 1, 2021 | June 30, 2023 |
| NCT00314132 | Completed | Phase 3 | Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis. | October 2005 | November 2006 |
| NCT00314145 | Completed | Phase 3 | A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX | November 2005 | November 2006 |
| NCT00319592 | Completed | Phase 2 | A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX | May 2005 | September 2006 |
| NCT00441259 | Completed | Phase 2 | Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age | January 2007 | December 2011 |
| NCT00463476 | Completed | Phase 4 | Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine | July 9, 2007 | October 2, 2008 |
| NCT00463684 | Completed | Phase 4 | Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age | July 7, 2007 | October 6, 2008 |
| NCT00594958 | Completed | Phase 3 | Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51 | September 2006 | September 2007 |
| NCT00595270 | Completed | Phase 3 | Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51 | October 2005 | April 2009 |
| NCT00595309 | Completed | Phase 3 | Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51 | December 2007 | October 2009 |
| NCT00595465 | Completed | Phase 3 | Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51 | December 2007 | June 2008 |
| NCT00595790 | Completed | Phase 3 | Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51 | September 2005 | November 2007 |
| NCT00596102 | Completed | Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51 | October 2005 | ||
| NCT00596271 | Completed | Phase 3 | Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440 | September 2005 | August 2008 |
| NCT00605085 | Completed | Phase 3 | Safety and Tolerability of the Japanese Encephalitis Vaccine IC51 | October 2005 | November 2006 |
| NCT00621764 | Completed | Phase 2 | Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children | March 2008 | May 2013 |
| NCT00694460 | Completed | Phase 2 | Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers | August 2002 | September 2004 |
| NCT00735644 | Completed | Phase 3 | Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines | August 2008 | August 2009 |
| NCT00776230 | Completed | Phase 3 | Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling | September 2008 | June 2010 |
| NCT00604708 | Completed | Phase 3 | Immunogenicity Study of the Japanese Encephalitis Vaccine IC51 | September 2005 | September 2006 |
| NCT02532569 | Completed | Phase 4 | Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj | August 2015 | October 2016 |
| NCT02602652 | Completed | N/A | Immunogenicity of a JE-CV as a Booster Dose After a Primary Vaccination With SA14-14-2 Vaccine | December 2013 | July 2015 |
| NCT02643433 | Completed | Phase 4 | Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines | August 2015 | June 2016 |
| NCT02816554 | Completed | Phase 2 | Safety and Immunogenicity of JECEVAX in Young Children | April 2015 | November 2015 |
| NCT02933710 | Completed | Postmarketing Surveillance Study for IMOJEV® in Republic of Korea | July 21, 2016 | October 18, 2018 | |
| NCT03204227 | Completed | Phase 2 | Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of Age | June 2, 2017 | August 12, 2017 |
| NCT03282370 | Completed | Phase 3 | Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam | September 30, 2017 | April 8, 2018 |
| NCT03920111 | Completed | N/A | Flavivirus Cross-priming Potential of IMOJEV | April 16, 2021 | May 11, 2022 |
| NCT00981175 | Completed | Phase 2 | A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults | April 2003 | February 2008 |
| NCT00981630 | Completed | Phase 2 | Study of Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine | November 2004 | November 2007 |
| NCT00982137 | Completed | Phase 2 | Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®) | July 2004 | March 2007 |
| NCT01001988 | Completed | Phase 3 | Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers | August 7, 2009 | October 16, 2013 |
| NCT01092507 | Completed | Phase 3 | A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers | March 2010 | October 2011 |
| NCT01150942 | Completed | Phase 3 | Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in Korea | August 2010 | February 2013 |
| NCT01158599 | Completed | Phase 4 | This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population | June 2010 | October 2011 |
| NCT01188343 | Completed | Phase 3 | Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers | August 2010 | December 2012 |
| NCT01190228 | Completed | Phase 3 | Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV | August 25, 2010 | October 12, 2015 |
| NCT01246479 | Completed | Phase 3 | Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study | October 2010 | September 2014 |
| NCT01296360 | Completed | Phase 3 | Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic Country | December 2010 | October 2013 |
| NCT01335412 | Completed | Safety Surveillance After Immunization With IXIARO | March 2011 | June 2013 | |
| NCT01386827 | Completed | Phase 3 | Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis | January 2008 | April 2011 |
| NCT01396512 | Completed | Phase 3 | Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in Toddlers | July 2011 | June 2013 |
| NCT01466387 | Completed | Phase 3 | A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults | November 2011 | April 2012 |
| NCT01567865 | Completed | Phase 4 | Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine | May 2012 | December 2012 |
| NCT01656200 | Completed | Phase 4 | A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2 | May 2012 | March 2014 |
| NCT01662440 | Completed | Phase 3 | Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Healthy Adult Subjects | August 2012 | October 2013 |
| NCT01815073 | Completed | Phase 4 | Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine | March 2013 | July 2013 |
| NCT01856205 | Completed | Phase 2 | Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis | May 2009 | August 2009 |
| NCT01900444 | Completed | Phase 3 | Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea | July 11, 2013 | March 11, 2014 |
| NCT01981967 | Completed | Phase 4 | Post-licensure Safety Study of IMOJEV® in Thailand | November 2013 | October 2015 |
| NCT02492165 | Completed | Phase 3 | Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects | June 2015 | June 2016 |
| NCT06331702 | Recruiting | Phase 4 | Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR) | March 2, 2024 | December 31, 2024 |
| NCT05568953 | Recruiting | Phase 2 | An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity | September 28, 2022 | October 2025 |
| NCT06372665 | Recruiting | Safety Observation of the Japanese Encephalitis Vaccine Given With a Primary Immunization | January 1, 2024 | June 30, 2025 | |
| NCT01954810 | Unknown status | Phase 4 | Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children | October 2013 | May 2014 |
| NCT00938379 | Unknown status | Phase 3 | Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR | July 2009 | June 2011 |
| NCT01163123 | Unknown status | Seroepidemiology of Japanese Encephalitis Virus Infection in Hualien, Taiwan | May 2010 | December 2010 | |
| NCT00216268 | Unknown status | Phase 2 | Treatment of Japanese Encephalitis | July 2005 | May 2008 |
| NCT01559831 | Withdrawn | Phase 1 | Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination | June 2012 | March 2013 |
- Disase is a (Disease Ontology)
- DOID:934
- Cross Reference ID (Disease Ontology)
- GARD:6797
- Cross Reference ID (Disease Ontology)
- ICD10CM:A83.0
- Cross Reference ID (Disease Ontology)
- ICD9CM:062.0
- Cross Reference ID (Disease Ontology)
- MESH:D004672
- Cross Reference ID (Disease Ontology)
- NCI:C34577
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:266194002
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0014057
- Exact Synonym (Disease Ontology)
- Japanese B encephalitis
- OrphaNumber from OrphaNet (Orphanet)
- 79139
- ICD10 preferred id (Insert disease from ICD10)
- D0000404
- ICD10 class code (Insert disease from ICD10)
- A83.0